Oral nanomedicines for sirna delivery to treat inflammatory bowel disease

HIGHLIGHTS

  • who: Jongyoon Shinn and colleagues from the College of Pharmacy, Ewha Womans University, Seoul , have published the research: Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease, in the Journal: Pharmaceutics 2022, 1969 of /2022/
  • future: The authors consider the challenges faced in the use of these strategies and future directions of oral siRNA delivery strategies.

SUMMARY

    The lumen of the GI tract is lined by smooth muscle cells, covered by mucus, submucosa, and several muscle layers of epithelial_cells, lamina propria, and muscularis mucosae. Internucleotide linkage modifications such as N30 . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?